An interventional study of Promoting First Relationships-Brief and Perinatal Integrated Care in Depression, Postpartum, Efficacy, Self and Anxiety, sponsored by University of Washington. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by University of Washington · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 220 studies in Depression, Postpartum with a site in United States — 38 open to participants now, 49 under way, 3 of them phase 3. Depression, Postpartum · United States.
Among the 220 studies in Depression, Postpartum with a site in United States, this one is the 176th largest by enrollment of the 198 interventional ones that give a count, is one of 12 that started in 2022, is one of 152 with no phase, and was the 139th registered.
570 studies on the registry are indexed under Depression, Postpartum; 135 are open to participants now.
Browse Depression, Postpartum studies →38 of the 220 studies in Depression, Postpartum with a site in United States are open now. Recruiting first, the newest first:
University of South Carolina · Sites in United States
Ages 18+ · Women only
University of Illinois at Chicago · Sites in United States
Ages 18+ · Women only
University of Florida · Sites in United States
Ages 15–49 · Women only
Lipocine Inc. · Sites in United States
Ages 15–45 · Women only
Northwestern University · Sites in United States
Ages 18+ · Women only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 88 Depression, Postpartum studies recruiting now, 54 (61%) set no upper age limit and 31 (35%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
220 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 20 · Phase 3 14 · Phase 4 7
First in 1996; this study’s year is marked. 12 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 16 is below the median of 103 across 455 interventional studies indexed under Depression, Postpartum.
Median enrollment 86 across the 198 interventional studies, 175 across the 22 observational. Of the 162 that completed or were terminated, 56 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 220 have an industry lead sponsor. The 10 most frequent:
University of Washington is the lead sponsor of 1,435 studies on the registry; 225 are open to participants now.
Of its 158 completed or terminated interventional studies of FDA-regulated products, 137 (87%) have results posted.
University of Washington has 2 studies filed under Depression, Postpartum — fewer than ten, so there is no comparison to draw.
22 of the studies in Depression, Postpartum with a site in United States that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05552053Phase 3Cedars-Sinai Medical CenterResources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women | 2026-12-31 |
| NCT07822321Phase 3Lipocine Inc.Brexanolone Lifting Outcomes Of Moms | 2027-08 |
| NCT05345834Children's National Research InstituteThe DC Mother-Infant Behavioral Wellness Program | 2026-11-30 |
| NCT06831968University of VirginiaClinical Validation of a Predictive Test for Postpartum Depression | 2026-11-30 |
| NCT06175104Children's Hospital Medical Center, CincinnatiHeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis | 2026-12 |
Add all 22 to your calendar (.ics) → With an account.
Among the 220 studies in Depression, Postpartum with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to assess the effectiveness of a parenting intervention+usual care compared to usual care on postpartum depression and other mental health and parenting outcomes, as well as the feasibility and acceptability of the parenting intervention.
Eligible and consenting participants will be randomized in a single blind manner (research visitor will be blinded to condition) at a 1:1 ratio to either MInD (parenting intervention and usual integrated care) or usual integrated care in their second trimester of pregnancy. Research assessments will be administered during pregnancy and post-partum.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Perinatal integrated care and Promoting First Relationships-Brief
Behavioral: Promoting First Relationships-Brief · Behavioral: Perinatal Integrated Care
Perinatal integrated care only
Behavioral: Perinatal Integrated Care
A brief version of the evidence based Promoting First Relationships (PFR) parenting intervention in which a parent is supported in appropriate interpretation of infant cues and in developing skills to effectively parent an infant. Sessions consist of reflective content (observing and reflecting back to the mother on patterns of dyadic interaction) and informational handouts. Reflective content will be delivered in person, and text messaging protocol will deliver informational content at developmentally appropriate times. PFR-B sessions are delivered in primary care settings beginning in the third trimester and continuing postpartum.
Integrated Care (IC) is an integrated care model that is effective in the treatment of perinatal depression. CC provides team driven, population focused, measurement guided and evidence based care to improve access and outcomes, control costs, and increase patient satisfaction.
Change From Baseline in Perinatal Depression on the PHQ-9
The PHQ-9 is a nine -item self-report depression measure with higher scores indicating increased symptom severity, total score ranging from 0 to 27 and is validated for use in the perinatal period.
Time frame: Baseline, 3 Months Postpartum, 6 Months Postpartum
Change From Baseline in Parental Self-Efficacy on the Self-Efficacy in a Nurturing Role (SENR)
The SENR contains 16 items rated on 7-point scales regarding mothers' perceptions of their competence on basic skills required in caring for an infant (e.g., "I feel confident in my role as a parent," "I can soothe my baby easily when he or she is crying or fussing") In the prenatal assessment questions address how women expect to do once their infant is born (e.g., "I look forward to becoming a parent with confidence in my role as a parent," "I expect to be able to soothe my baby easily when he or she is crying or fussing"). Scores on the SENR are obtained by summing individual items to yield a total efficacy score, with higher scores reflecting greater feelings of efficacy. Minimum score is 16 and maximum score is 112.
Time frame: Baseline, 3 Months Postpartum, 6 Months Postpartum
Change From Postpartum Baseline in Dyadic Interaction
The Nursing Child Assessment Teaching Scale (NCAST) is an observational measure of the quality of caregiver-child dyadic interaction during a brief teaching activity, assessing caregiver sensitivity, responsiveness, and behaviors that foster the child's social-emotional and cognitive development. The caregiver subscale consists of four caregiver subscales comprising 50 items. Each item is scored dichotomously (0 = behavior not observed; 1 = behavior observed), giving a total caregiver score range of 0-50. Higher scores indicate more favorable caregiver-child interaction, reflecting greater caregiver sensitivity. NCATS is scored by observing a 3 minute videotaped session of mother and child interactive behavior.
Time frame: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
Change From Baseline in Disability on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)
WHODAS 2.0 is a 12 item assessment of overall functioning. The scores assigned to each of the items - "none" (0), "mild" (1) "moderate" (2), "severe" (3) and "extreme" (4) - are summed, total score ranging from 0 to 48. Higher scores indicate higher disability, that is higher values indicate a worse outcome.
Time frame: Baseline, 3 Months Postpartum, 6 Months Postpartum
Change From Postpartum Baseline in Maternal Functioning on the Barkin Index of Maternal Functioning (BIMF)
The BIMF is a 20-item self-report measure for use in the first year postpartum and can assess overall functioning in the context of new motherhood. It measures the functional domains of social support, management, mother-child interaction, infant care, self-care, adjustment, and psychological well-being (of the mother). It is measured only postpartum. A total score is generated from summing the 20 items and ranges from 0 to 120. Higher scores indicate better maternal functioning, a better outcome.
Time frame: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
Change in Working Alliance Inventory - Short Revised (WAI-SR) Scores Over Time
The WAI-SR is a measure of therapeutic alliance. It contains 12 items using a 5 point likert scale. Score range is 12 to 60, with higher scores indicating better therapeutic alliance, a better outcome.
Time frame: Prenatal to 6 months PP
Only pregnant mothers were enrolled, their infants were not enrolled into the study as participants. The study is described as dyadic as it addresses parenting in addition to depression. Care managers were not randomized and no quantitative data was collected from them.
| Milestone | Intervention Group | Control |
|---|---|---|
| Started | 8 | 8 |
| Completed | 6 | 5 |
| Not completed | 2 | 3 |
The PHQ-9 is a nine -item self-report depression measure with higher scores indicating increased symptom severity, total score ranging from 0 to 27 and is validated for use in the perinatal period.
| scores on a scale | Intervention | Control |
|---|---|---|
| Baseline | 13.88 ± 4.12 | 12.38 ± 5.66 |
| 3 months PP | 8.33 ± 2.25 | 10.83 ± 8.75 |
| 6 months PP | 6.33 ± 2.5 | 12 ± 6.4 |
The SENR contains 16 items rated on 7-point scales regarding mothers' perceptions of their competence on basic skills required in caring for an infant (e.g., "I feel confident in my role as a parent," "I can soothe my baby easily when he or she is crying or fussing") In the prenatal assessment questions address how women expect to do once their infant is born (e.g., "I look forward to becoming a parent with confidence in my role as a parent," "I expect to be able to soothe my baby easily when he or she is crying or fussing"). Scores on the SENR are obtained by summing individual items to yield a total efficacy score, with higher scores reflecting greater feelings of efficacy. Minimum score is 16 and maximum score is 112.
| scores on a scale | Intervention | Control |
|---|---|---|
| Baseline | 90.25 ± 19.96 | 87.33 ± 23.73 |
| 3 months PP | 93.67 ± 21.37 | 91.17 ± 15.79 |
| 6 months PP | 100.17 ± 17.99 | 90 ± 12.92 |
The Nursing Child Assessment Teaching Scale (NCAST) is an observational measure of the quality of caregiver-child dyadic interaction during a brief teaching activity, assessing caregiver sensitivity, responsiveness, and behaviors that foster the child's social-emotional and cognitive development. The caregiver subscale consists of four caregiver subscales comprising 50 items. Each item is scored dichotomously (0 = behavior not observed; 1 = behavior observed), giving a total caregiver score range of 0-50. Higher scores indicate more favorable caregiver-child interaction, reflecting greater caregiver sensitivity. NCATS is scored by observing a 3 minute videotaped session of mother and child interactive behavior.
| scores on a scale | Intervention | Control |
|---|---|---|
| 6 weeks PP | 37.67 ± 5.68 | 37 ± 4.95 |
| 3 months PP | 40.33 ± 3.56 | 38.5 ± 9.09 |
| 6 months PP | 35.60 ± 5.37 | 33.60 ± 8.17 |
WHODAS 2.0 is a 12 item assessment of overall functioning. The scores assigned to each of the items - "none" (0), "mild" (1) "moderate" (2), "severe" (3) and "extreme" (4) - are summed, total score ranging from 0 to 48. Higher scores indicate higher disability, that is higher values indicate a worse outcome.
| scores on a scale | Intervention | Control |
|---|---|---|
| Baseline | 41.67 ± 13.55 | 37.24 ± 13.24 |
| 3 months PP | 21.18 ± 16.64 | 24.65 ± 9.07 |
| 6 months PP | 11.81 ± 11.08 | 21.67 ± 9.39 |
The BIMF is a 20-item self-report measure for use in the first year postpartum and can assess overall functioning in the context of new motherhood. It measures the functional domains of social support, management, mother-child interaction, infant care, self-care, adjustment, and psychological well-being (of the mother). It is measured only postpartum. A total score is generated from summing the 20 items and ranges from 0 to 120. Higher scores indicate better maternal functioning, a better outcome.
| scores on a scale | Intervention | Control |
|---|---|---|
| 6 weeks PP | 91.29 ± 14.92 | 93.17 ± 17.95 |
| 3 months PP | 96.4 ± 12.22 | 88.17 ± 22.66 |
| 6 months PP | 99.67 ± 11.27 | 89.2 ± 18.82 |
The WAI-SR is a measure of therapeutic alliance. It contains 12 items using a 5 point likert scale. Score range is 12 to 60, with higher scores indicating better therapeutic alliance, a better outcome.
| scores on a scale | Intervention | Control |
|---|---|---|
| Prenatal | 48.94 ± 11.27 | 49.38 ± 7.29 |
| 6 months PP | 52.50 ± 10.05 | 53.73 ± 5.64 |
Collected over From baseline up to final assessment at 6 months PP. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Intervention | 0/8 (0%) | 0/8 (0%) | 2/8 (25%) |
| Control | 0/8 (0%) | 0/8 (0%) | 4/8 (50%) |
| Event | Intervention | Control |
|---|---|---|
| Suicidal ideationPsychiatric disorders | 2/8 | 4/8 |
| Age, Continuous(years) | Intervention | Control | Total |
|---|---|---|---|
| Mean | 32.19 ± 7.42 | 30.11 ± 5.2 | 31.15 ± 6.28 |
| Sex: Female, Male(Participants) | Intervention | Control | Total |
|---|---|---|---|
| Female | 8 | 8 | 16 |
| Male | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Intervention | Control | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 3 | 1 | 4 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 |
| White | 3 | 6 | 9 |
| More than one race | 1 | 1 | 2 |
| Unknown or Not Reported | 1 | 0 | 1 |
| Ethnicity (NIH/OMB)(Participants) | Intervention | Control | Total |
|---|---|---|---|
| Hispanic or Latino | 0 | 1 | 1 |
| Not Hispanic or Latino | 7 | 7 | 14 |
| Unknown or Not Reported | 1 | 0 | 1 |
| Patient Health Questionnaire - 9(scores on a scale) | Intervention | Control | Total |
|---|---|---|---|
| Mean | 13.88 ± 4.12 | 12.38 ± 5.66 | 13.13 ± 4.84 |
PDFs hosted by the registry, ClinicalTrials.gov.
Ran from Nov 2022 to primary completion in Apr 2025, 29 months.
Results were first posted in Nov 2026, 1 year 6 months after primary completion.
Of 259 non-industry interventional studies with no phase under Depression, Postpartum, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's 29 months is above that.
Counting every sponsor, half of 265 studies reached it within 23 months; a quarter within 11 and three quarters within 35.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: primary completion Mar 2025 → Apr 2025 and completion Jun 2025 → Apr 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.